Q-omics provides the consensus-scored ADAM5 profile across patient tissues and cancer cell-line models. ADAM5 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, ADAM5 RNA expression shows 6,138 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where ADAM5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.